Submit to Current Oncology Review for Current Oncology

Journal Menu

Journal Browser

Breast Cancer

A section of Current Oncology (ISSN 1718-7729).

Section Information

The Section on Breast Cancer in Current Oncology is currently open to contemporary articles examining basic, translational, and clinical research on all aspects related to breast cancer, with an emphasis on manuscripts which may impact our understanding or treatment of the disease. This includes studies addressing the epidemiology and pathology of breast cancer as well as studies on the outcomes of both early and advanced breast cancer. Manuscripts that report on novel treatments or add to the knowledge of current therapies with new insights regarding predictive or prognostic factors, toxicity, pharmacogenomics or associated novel innovations, and new enabling technologies are of interest. Studies of promising imaging techniques for both screening and during treatment, as well as trials of pathology and genomic testing of tumour and host, are also welcome. Topics that reflect patient related outcomes and supportive care, particularly in the advanced setting and may impact patterns of care for breast cancer specialists as well as general health care providers may be important publications, particularly if related to clinical cancer outcomes. Emphasis will be placed on both creative work and knowledge that has pragmatic potential.

Additional topics of interest include:

Registry-based studies that provide insight into treatment effectiveness;
Evidence-based knowledge synthesis and knowledge translation related to breast cancer, including prognostic and predictive factors or novel host factors, such as immune system regulatory factors, inherited genetic predisposition or pharmacogenomics;
Studies that identify patient subgroups who may or may not benefit from specific treatments, including issues of toxicity, disparities, or underserved populations;
Interprofessional approaches, training, and education that support treatment strategies; regulatory and quality issues related to the treatment of breast cancer;
Insight from preclinical animal models that advance new concepts or identify mechanisms related to the epidemiology or treatment of breast cancer.